77 related articles for article (PubMed ID: 10924700)
1. Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine.
Ho M; Segre M
Brain Res; 2000 Jul; 872(1-2):231-5. PubMed ID: 10924700
[TBL] [Abstract][Full Text] [Related]
2. Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines.
Ho M; Segre M
Neurosci Lett; 2001 Feb; 299(3):229-33. PubMed ID: 11165777
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of the human dopamine transporter in a neuronal cell line.
Zhang L; Elmer LW; Little KY
Brain Res Mol Brain Res; 1998 Aug; 59(1):66-73. PubMed ID: 9729282
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties.
Ho M; Segre M
Biochim Biophys Acta; 2003 Jul; 1638(3):257-66. PubMed ID: 12878327
[TBL] [Abstract][Full Text] [Related]
5. Cloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of an Ab2beta anti-idiotypic monoclonal antibody possessing an internal image of cocaine.
Ho M; Segre M
Biochim Biophys Acta; 2001 Oct; 1521(1-3):135-40. PubMed ID: 11690646
[TBL] [Abstract][Full Text] [Related]
6. Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies.
Schabacker DS; Kirschbaum KS; Segre M
Immunology; 2000 May; 100(1):48-56. PubMed ID: 10809958
[TBL] [Abstract][Full Text] [Related]
7. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
9. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development.
Uhl G; Lin Z; Metzger T; Dar DE
Methods Enzymol; 1998; 296():456-65. PubMed ID: 9779467
[No Abstract] [Full Text] [Related]
11. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent.
Mayfield RD; Zahniser NR
Mol Pharmacol; 2001 Jan; 59(1):113-21. PubMed ID: 11125031
[TBL] [Abstract][Full Text] [Related]
13. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
Chen N; Trowbridge CG; Justice JB
J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter.
Simantov R; Blinder E; Ratovitski T; Tauber M; Gabbay M; Porat S
Neuroscience; 1996 Sep; 74(1):39-50. PubMed ID: 8843076
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the human dopamine transporter heterologously expressed in BHK-21 cells.
Lenhard T; Marheineke K; Lingen B; Haase W; Hammermann R; Michel H; Reiländer H
Cell Mol Neurobiol; 1998 Jun; 18(3):347-60. PubMed ID: 9590564
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.
Park SU; Ferrer JV; Javitch JA; Kuhn DM
J Neurosci; 2002 Jun; 22(11):4399-405. PubMed ID: 12040046
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a recombinant human dopamine transporter in multiple cell lines.
Eshleman AJ; Neve RL; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
[TBL] [Abstract][Full Text] [Related]
20. Multisubtrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine.
Earles C; Schenk JO
Synapse; 1999 Sep; 33(3):230-8. PubMed ID: 10420170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
